Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors

MLA

Cho Yeow Koh, et al. “Efficacy and Safety of Next-Generation Tick Transcriptome-Derived Direct Thrombin Inhibitors.” Nature Communications, vol. 12, no. 1, Nov. 2021, pp. 1–16. EBSCOhost, https://doi.org/10.1038/s41467-021-27275-8.

APA

Cho Yeow Koh, Norrapat Shih, Christina Y. C. Yip, Aaron Wei Liang Li, Weiming Chen, Fathiah S. Amran, Esther Jia En Leong, Janaki Krishnamoorthy Iyer, Grace Croft, Muhammad Ibrahim Bin Mazlan, Yen-Lin Chee, Eng-Soo Yap, Dougald M. Monroe, Maureane Hoffman, Richard C. Becker, Dominique P. V. de Kleijn, Vaishali Verma, Amita Gupta, Vijay K. Chaudhary, … Mark Y. Chan. (2021). Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors. Nature Communications, 12(1), 1–16. https://doi.org/10.1038/s41467-021-27275-8

Chicago

Cho Yeow Koh, Norrapat Shih, Christina Y. C. Yip, Aaron Wei Liang Li, Weiming Chen, Fathiah S. Amran, Esther Jia En Leong, et al. 2021. “Efficacy and Safety of Next-Generation Tick Transcriptome-Derived Direct Thrombin Inhibitors.” Nature Communications 12 (1): 1–16. doi:10.1038/s41467-021-27275-8.